U.S. Software Stock News

NasdaqGS:INMD
NasdaqGS:INMDMedical Equipment

Is InMode (INMD) Priced Attractive After Recent 7% Monthly Share Price Gain

Wondering if InMode at around US$15.71 is a bargain or a value trap? This article will walk you through what the current price might be implying. The stock has returned 12.6% over the last 7 days and 6.9% over the last 30 days, although the 1 year return of 8.7% and 3 year return of 57.8% show a very different experience for longer term holders. That mix of shorter term gains and weaker multi year returns has kept attention on how the market is reassessing InMode, with many investors...
NasdaqGS:ARLP
NasdaqGS:ARLPOil and Gas

Alliance Resource Warns Mountain View Mine Workers As Coal Demand Shifts

Alliance Resource Partners (NasdaqGS:ARLP) has issued WARN Act notices to all employees at its Mettiki subsidiary’s Mountain View Mine. The move follows reduced coal demand from a key customer and raises the possibility of a permanent closure of the mine. The decision affects hundreds of jobs and could have material implications for future coal sales volumes and asset values. For investors watching Alliance Resource Partners, the Mountain View Mine news lands as the units trade around...
NYSE:KRC
NYSE:KRCOffice REITs

Is Kilroy Realty (KRC) Pricing Reflect Long Term Value After Multi Year Share Price Decline

If you are wondering whether Kilroy Realty's share price reflects its true worth, you are not alone. This article is meant to help you weigh that question clearly. The stock last closed at US$34.48, with returns of a 3.1% decline over 7 days, a 7.7% decline over 30 days, a 9.3% decline year to date, a 6.3% decline over 1 year and a 24.4% decline over 5 years, while the 3 year return stands at 2.1%. Recent moves in office and real estate investment trust names have kept attention on how the...
NYSE:TGNA
NYSE:TGNAMedia

Will TEGNA's (TGNA) Mobile App Push and Award-Winning Journalism Deepen Its Local-Media Moat?

TEGNA Inc. recently rolled out new personalized local news and weather apps across 50 markets and saw audience engagement climb, while its Atlanta NBC affiliate WXIA (11Alive) won the 2026 Alfred I. duPont-Columbia University Award for the “Help That Harms” investigation that drove statewide policy reforms in Georgia. Together, the surge in mobile usage and high-profile recognition for impactful journalism underscore TEGNA’s strengthening connection with local audiences and public...
NYSE:SPHR
NYSE:SPHREntertainment

Sphere Entertainment Tests Smaller Sphere Model With Maryland National Harbor Plan

Sphere Entertainment (NYSE:SPHR) announced plans for a new venue at National Harbor in Maryland, its second U.S. location. The project will use a smaller scale design compared with the company’s existing U.S. venue. The development is expected to bring Sphere’s immersive entertainment concept to the Washington, D.C. metropolitan area. Company communications highlight anticipated economic, cultural, and community impacts, including job creation and public private investment. Sphere...
NYSE:HTH
NYSE:HTHBanks

Hilltop Holdings Ups Dividend And Buybacks As Earnings Strengthen

Hilltop Holdings (NYSE:HTH) raised its quarterly dividend by 11% following its latest full year results. The company also authorized a new US$125 million share repurchase program. These capital return actions arrive after a year of improved profitability and strong financial performance. For you as an investor, this move puts fresh attention on Hilltop Holdings, a financial services company active in banking and other related lines of business. The higher dividend and new buyback plan come...
NasdaqGS:OLMA
NasdaqGS:OLMABiotechs

Is It Too Late To Consider Olema Pharmaceuticals (OLMA) After Its 320% One-Year Surge?

If you are wondering whether Olema Pharmaceuticals is still priced attractively after its recent run, this article walks through the numbers in a clear, valuation focused way. The stock recently closed at US$25.72, with returns of 1.9% over 7 days, 2.9% over 30 days, 1.7% year to date and 320.9% over the past year, while the 3 year return sits at 465.3% and the 5 year return at a 45.7% decline. Recent attention on Olema has centered on its position in the pharmaceuticals and biotech space...